Delivery Order 36F79720D0017-36C24526N0555

<p>Veterans Integrated Service Network 5 issued a delivery order to Dompe U.S. Inc. on August 4, 2023, with a ceiling value of $224,082.24 for OXERVATE 0.002% solution under the GSA Pharmaceuticals and Drugs schedule (FSS-61-IB).</p> <p>Place of performance is Bartlett, TN. The order is firm fixed price with an ultimate completion date of June 23, 2026. No set-aside was used.</p>

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, under the GSA Pharmaceuticals and Drugs schedule (FSS-61-IB). The order is for the supply of Oxervate (cenegermin-bkbj) 0.002% ophthalmic solution, a medication used to treat neurotrophic keratitis. The $39,774.12 order was placed by the VA's Veterans Integrated Service Network 5 to fulfill medication needs at VA facilities. Dompe U.S. Inc....

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Ozurdex 0.7 mg implants, with a ceiling value of $2,050.84. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 18, 2026, with a ceiling value of $4,101.68 for Ozurdex 0.7 mg implants, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order is firm fixed price with an ultimate completion date of April 8, 2026. PPV-G GEN V is a Defense Logistics Agency indefinite delivery...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for Ozurdex 0.7 mg implants with a ceiling value of $3,076.23, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. The contract was awarded to DMS Pharmaceutical Group on...

<p>Veterans Integrated Service Network 10 issued a delivery order to Omnicell, Inc. on April 1, 2025, with a ceiling value of $205,744.50 for Omnicell maintenance and support services at two locations—Dayton, OH and Chicago, IL.</p> <p>The order is issued under the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A). Place of performance is Dayton, OH 45428. The order is firm fixed price with an ultimate completion date of September 30, 2025. No set-aside was used.</p>

The Defense Logistics Agency issued a $5,127.05 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for OZURDEX 0.7 mg implants under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order has a firm fixed price and an ultimate completion date of March 27, 2026. The parent PPV-G GEN V contract,...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, with a ceiling value of $31,268.34 for Ocrevus 300 mg/10 mL vials. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of April 22, 2026.

The Defense Logistics Agency issued a firm fixed-price delivery order valued at $8,821.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml syringes. The delivery order, awarded on January 5, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement environment. This delivery order is...

The Defense Logistics Agency awarded a delivery order valued at $3,016.14 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Ozurdex 0.7 mg implants. This firm fixed-price delivery order, which carries an ultimate completion date of October 1, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The delivery order does not utilize a set-aside designation and will be performed at the contractor's...